Tag: Cancer
-
Low Vitamin D Predicts Aggressive Prostate Cancer
A new Northwestern Medicine study showed that deficient vitamin D blood levels in men can predict aggressive prostate cancer.
-
Examining New Breast Cancer Therapy
A phase III clinical trial tested the effectiveness of a combination of two drugs and found they may be an effective and safe treatment for patients with metastatic breast cancer.
-
Nanoparticles Destroy Cancer With Mechanical Force
By rotating special magnetic nanoparticles injected into brain tumors, a team of scientists led by Northwestern Medicine neurosurgical oncologist Maciej (Matt) Lesniak, MD, successfully damaged tumor cells in animal models.
-
Overcoming Barriers to Clinical Trial Participation
Patients with cancer who watched personalized educational videos before their first visit with an oncologist were better equipped to consider participating in clinical trials, reports a paper co-authored by Northwestern Medicine investigator Al B. Benson, III, MD.
-
Scientists Pinpoint Place Where Cancer Cells May Begin
Northwestern University scientists used fruit fly genetics to understand how developing cells normally switch to a restricted, or specialized, state and how that process might go wrong in cancer.
-
Medical Student Focuses on Cancer Research
First-year medical student Martin Mutonga was the first author of a recent paper that identified a potential drug target in acute lymphoblastic leukemia.
-
Mutation Unique to Childhood Kidney Cancer Discovered
A recent study led by Elizabeth Perlman, MD, discovered a new genetic mutation in the most common type of pediatric kidney cancer, Wilms tumor.
-
Targeting Immunosuppression in Brain Tumors
Research conducted in the laboratory of Derek Wainwright, PhD, assistant professor of Neurological Surgery, explores strategies to reverse pathways that inhibit the body’s immune system from fighting glioblastoma.
-
Accelerating Prostate Cancer Research
Northwestern Medicine scientists have received a five-year, $11 million grant from the National Institutes of Health National Cancer Institute (NCI) to lead a Specialized Program of Research Excellence (SPORE) in prostate cancer.
-
Patient-Centered Innovation
New neurosurgery chair, Maciej S. Lesniak, MD, MHCM, combats brain cancer with a multifaceted biological approach.
